VJHemOnc Podcast cover image

iwNHL 2023 Session V: Expanding the CAR platform in NHL

VJHemOnc Podcast

00:00

Comparing CAR T-cell therapies and exploring alternative antigens and off-the-shelf options in cancer treatment

This chapter explores the efficacy of CD-19 targeted CAR T-cells compared to standard chemotherapy and transplant approaches in second-line treatment for cancer. It also discusses the possibility of creating autologous CAR T-cell products targeting different antigens and the potential of allogeneic or off-the-shelf CAR T-cell therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app